Skip to main content
. 2016 Sep 16;7(45):73800–73816. doi: 10.18632/oncotarget.12070

Table 2. Cox regression model.

n Multivariate****
Univariate with T, N and T/N
HR 95% CI p HR 95% CI p
ESRP1_T
<66.67 25 ref ref
>=66.67 43 0.30 0.12 - 0.74 0.009 0.36 0.15 - 0.91 0.032
ESRP1_N
<66.67 17 ref ref
>=66.67 51 0.56 0.22 - 1.41 0.217 0.38 0.12 - 1.15 0.087
ESRP1_T/N
<0.269 22 ref ref
>=0.269 45 0.47 0.19 - 1.14 0.094 0.43 0.15 - 1.22 0.113
ESRP2_T
<131.1 29 ref ref
>=131.1 39 0.26 0.10 - 0.69 0.006 0.23 0.08 - 0.65 0.006
ESRP2_N
<131.1 18 ref ref
>=131.1 50 0.62 0.25 - 1.55 0.304 0.56 0.18 - 1.72 0.309
ESRP2_T/N
<0.668 41 ref ref
>=0.668 26 2.11 0.87 - 5.09 0.097 2.10 0.76-5.80 0.153
Instability
Instable 11 ref
stable 57 1.04 0.30 - 3.54 0.954
Gender
f 26 ref
m 42 1.29 0.51 −3.23 0.589
Tumor site
rectum 13 ref
colon 55 0.67 0.24-1.85 0.443
Grade
2 45 ref
3 22 1.21 0.48 - 3.04 0.685
Stage
I 11 ref
II 28 0.85 0.22 - 3.29 0.815
III-IV 29 1.39 0.38 - 5.00 0.629
p-trend 1.28 0.67 - 2.44 0.455
Age 1.05 1.00 - 1.10 0.068
****

adjusted with age, stage, grade, tumor site, gender, microsatellite stability for each gene expression in each type of tissue in bold are marked p values <0.1.